TradingAgents AISign inGet started
All stock profiles
JPMNYSEFinancial Services

JPMORGAN CHASE & CO

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$334.49

-0.84%

Alpha Vantage · 11/6/2026

Industry: Banks - DiversifiedCategory: Domestic Common Stock Primary ClassCurrency: USDNews: 8 recent
Analyze JPM free

One-year price history

Adjusted daily closes · 252 observations · as of Nov 6, 2026

Historical data, not a forecast

1 month

+0.9%

3 months

-6.6%

6 months

+11.8%

1 year

+8.8%

Year to date

+5.8%

52-week range

$278.78 – $363.37

Fundamental snapshot

Latest reported period: Sep 30, 2026

Sharadar reported data

Market cap

$888.27B

P/E

13.8

P/B

2.4

P/S

4.4

Revenue

$203.15B

Net income

$64.53B

Diluted EPS

23.85

Gross margin

100.00%

Net margin

31.80%

Return on equity

17.50%

Total debt

$1.23T

Cash

$326.27B

Free cash flow

-$84.16B

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Sep 30, 2026$50.17B$14.94B100.00%29.80%$33.16B
Jun 30, 2026$57.35B$20.75B100.00%36.20%-$25.28B
Mar 31, 2026$49.84B$16.15B100.00%32.40%-$211.76B
Dec 31, 2025$45.8B$12.69B100.00%27.70%$119.72B
Sep 30, 2025$46.43B$14.04B100.00%30.20%-$45.21B
Jun 30, 2025$44.91B$14.63B100.00%32.60%$29.55B
Mar 31, 2025$45.31B$14.32B100.00%31.60%-$251.84B
Dec 31, 2024$42.77B$13.67B100.00%32.00%$147.76B

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent JPM news

All market news
MarketBeat·62 signal
Public Storage $PSA Stock Position Raised by Rakuten Investment Management Inc.

Rakuten Investment Management Inc. significantly increased its stake in Public Storage (NYSE:PSA) during the third quarter, adding 4,310 shares to hold a total of 30,151 shares valued at $8.6 million. This increase comes as Public Storage reported mixed quarterly results, missing EPS estimates but exceeding revenue forecasts. The company also announced a quarterly dividend of $3 per share, yielding 3.5%, and received a "Hold" consensus rating from analysts with an average price target of $325.79.

Original source
Investing.com·70 signal
JPMorgan upgrades Sociedad Quimica y Minera stock rating on valuation

JPMorgan has upgraded Sociedad Quimica y Minera (SQM) to Overweight from Neutral, despite lowering its price target to $71 from $88 due to reduced lithium price assumptions. The firm anticipates global lithium deficits in 2026 and 2027, driven by battery energy storage system demand, which could lead to a significant recovery in lithium prices. JPMorgan views SQM as undervalued and expects strong volume and cost performance, preferring it over Sigma Lithium in the Latin American lithium sector.

Original source
MarketBeat·67 signal
2,980 Shares of The Goldman Sachs Group, Inc. $GS Bought by Associated Banc Corp

Associated Banc Corp recently initiated a new position in The Goldman Sachs Group, acquiring 2,980 shares valued at approximately $2.68 million. This move is part of broader institutional investor activity, with hedge funds and other institutional investors collectively owning 71.21% of Goldman Sachs stock. The investment comes as Goldman Sachs reported strong quarterly earnings, beating analyst estimates with an EPS of $17.01 and a 23% year-over-year revenue increase to $18.68 billion, alongside declaring a $5 quarterly dividend.

Original source
MarketBeat·59 signal
KKR & Co. Inc. $KKR Holdings Reduced by City of London Investment Management Co. Ltd.

City of London Investment Management Co. Ltd. significantly cut its stake in KKR & Co. Inc. by 94% in the third quarter, reducing its holdings to 4,390 shares valued at $401,000. Despite this reduction and an insider sale by Dane Holmes, institutional investors and hedge funds collectively own 76.26% of KKR shares. Analysts maintain a "Moderate Buy" consensus rating for KKR with an average price target of $123.58.

Original source
MarketBeat·62 signal
8,834 Shares of Bank Of Montreal $BMO Bought by Associated Banc Corp

Associated Banc Corp has acquired a new position in Bank Of Montreal (NYSE:BMO), purchasing 8,834 shares valued at approximately $1,477,000 during the third quarter. Other institutional investors also made significant purchases. Bank Of Montreal recently reported strong quarterly earnings, beating analyst estimates, and declared a quarterly dividend of C$1.71 per share.

Original source
MarketBeat·64 signal
Associated Banc Corp Purchases New Shares in Amcor PLC $AMCR

Associated Banc Corp has initiated a new position in Amcor PLC, acquiring 43,395 shares valued at approximately $1.82 million. Analysts currently hold a "Moderate Buy" consensus rating for Amcor with an average price target of $49.36. Despite reporting quarterly revenue of $6.13 billion, which exceeded estimates, Amcor's earnings per share of $0.95 narrowly missed consensus projections.

Original source
MarketBeat·61 signal
53,416 Shares of Wells Fargo & Company $WFC Bought by Associated Banc Corp

Associated Banc Corp recently purchased 53,416 shares of Wells Fargo & Company (NYSE:WFC) worth approximately $4,276,000 in the third quarter. Other institutional investors also initiated new positions in WFC, with 75.90% of the stock owned by institutional investors and hedge funds. Wells Fargo reported strong earnings, topping consensus estimates, announced a quarterly dividend of $0.50 per share, and received a "Moderate Buy" consensus rating from analysts with an average price target of $98.11.

Original source
Stock Titan·58 signal
About 1 in 70,000 males have a rare genetic disorder. ANI offered $560 million for the company behind its approved treatment.

ANI Pharmaceuticals has made a public offer to acquire Egetis Therapeutics for approximately SEK 5.6 billion ($560 million). The acquisition aims to expand ANI's rare disease business by adding EMCITATE, an approved treatment for MCT8 deficiency, which ANI estimates could achieve peak sales of over $300 million with patent protection extending into mid-2045. Egetis's board unanimously recommends the offer, and shareholders representing about 42% of outstanding shares have committed to accept, with the deal contingent on 90% shareholder acceptance and regulatory approvals.

Original source